Urokinase plasminogen activator and cathepsin D in micrometastatic cells of patients with primary breast cancer

被引：0
|
作者：
Solomayer, EF [1 ]
Diel, IJ [1 ]
Gollan, C [1 ]
Meyberg, G [1 ]
Bode, S [1 ]
Wallwiener, D [1 ]
Bastert, G [1 ]
机构：
[1] Univ Heidelberg, Dept OB GYN, D-69115 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89259-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P41
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [31] The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    Ross W. Stephens
    Nils Brünner
    Fritz Jänicke
    Manfred Schmitt
    Breast Cancer Research and Treatment, 1998, 52 : 99 - 111
  • [32] Urokinase-type plasminogen activator system and breast cancer (Review)
    Han, B
    Nakamura, M
    Mori, I
    Nakamura, Y
    Kakudo, K
    ONCOLOGY REPORTS, 2005, 14 (01) : 105 - 112
  • [33] DISREGULATION OF UROKINASE PLASMINOGEN-ACTIVATOR GENE IN BREAST-CANCER
    HUBBARD, AL
    LAUDER, J
    HAWKINS, RA
    ANDERSON, TJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (01) : 103 - 107
  • [34] The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    Stephens, RW
    Brünner, N
    Jänicke, F
    Schmitt, M
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 99 - 111
  • [35] In vitro suppression of urokinase plasminogen activator in breast cancer cells -: A comparison of two antisense strategies
    Arens, N
    Gandhari, M
    Bleyl, U
    Hildenbrand, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (01) : 113 - 119
  • [36] Plasmatic plasminogen activator inhibitor activity in patients with primary breast cancer
    vonTempelhoff, GF
    Heilmann, L
    Dietrich, M
    Schneider, D
    Niemann, F
    Hommel, G
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (03) : 606 - 608
  • [37] Reference gene selection to quantify urokinase plasminogen activator in breast cancer
    Esmaeili, R.
    Majidzadeh-A, K.
    Abdoli, N.
    Habibi, M.
    Bahrami, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 112 - 112
  • [38] Clinical significance of urokinase plasminogen activator and its receptor in breast cancer
    Duffy, MJ
    Duggan, C
    Maguire, T
    McDermott, E
    OHiggins, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 879 - 879
  • [39] Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors
    T Jahkola
    T Toivonen
    K von Smitten
    I Virtanen
    V-M Wasenius
    C Blomqvist
    British Journal of Cancer, 1999, 80 : 167 - 174
  • [40] Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors
    Jahkola, T
    Toivonen, T
    von Smitten, K
    Virtanen, I
    Wasenius, VM
    Blomqvist, C
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 167 - 174
12345